Completed PHASE4 INTERVENTIONAL NCT00494247

Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes (JACK-EPC)

Comparison of Efficiency of High Dose Atorvastatin and Endothelial Progenitor-Capture Stents and Bare Metal Stents in Reduction of Neointimal Formation in Patients With Non ST-Segment Elevation Acute Coronary Syndromes

Sponsor: Ministry of Science and Higher Education, Poland

Conditions Acute Coronary Syndromes Coronary Heart Disease

Interventions coronary stent (Genous, OrbusNeich) with immobilised anti-CD34 antibody to capture circulating endothelial progenitor cells

Updated 6 times since 2017 Last updated: Jun 18, 2010 Started: Oct 31, 2007 Primary completion: Jun 30, 2009 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Coronary Syndromes and Coronary Heart Disease and is currently completed. Ministry of Science and Higher Education, Poland leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Science and Higher Education, Poland
Silesian School of Medicine

Data source: Silesian School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Katowice, Poland
• Ustroń, Poland